Cargando…

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction

Detalles Bibliográficos
Autores principales:	Eastman, Jacqueline, Kelbel, Theodore, Holsworth, Amanda, Pebbles, Timothy, Hartog, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540009/ https://www.ncbi.nlm.nih.gov/pubmed/34699971 http://dx.doi.org/10.1016/j.anai.2021.10.023

Ejemplares similares

Multiple doses of icatibant used during pregnancy
por: Kaminsky, Lauren W., et al.
Publicado: (2017)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Why some people tolerate the second dose of a vaccine but not the first dose
por: Yu, Yihua Bruce, et al.
Publicado: (2022)

Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019
por: Hartog, Nicholas, et al.
Publicado: (2021)

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience
por: Puxkandl, Viktoria, et al.
Publicado: (2022)

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
por: Vanijcharoenkarn, Kristine, et al.
Publicado: (2021)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose
por: Apostolidou, Evaggelia, et al.
Publicado: (2023)

Association between Adverse Reactions to the First and Second Doses of COVID-19 Vaccine
por: Goda, Ken, et al.
Publicado: (2022)

NACI greenlights second doses, dose splitting of monkeypox vaccine
por: Vogel, Lauren
Publicado: (2022)

Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
por: Wu, Xiaotian, et al.
Publicado: (2021)

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
por: Greenberg, Ross S., et al.
Publicado: (2021)

Adverse events after administration of the first and second doses of messenger RNA-based COVID-19 vaccines in Japanese subjects aged 12–18 years
por: Ogawa, Taku, et al.
Publicado: (2022)

Pregnancy should be a condition eligible for additional doses of COVID-19 messenger RNA vaccines
por: Faust, Jeremy Samuel, et al.
Publicado: (2023)

Patients with Pseudoallergic Reactions Following COVID-19 Vaccination are Able to Tolerate Subsequent Dosing
por: Patterson, Alexander, et al.
Publicado: (2022)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
por: Ricardo, Jose W., et al.
Publicado: (2021)

Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third Dose
por: Panarese, A., et al.
Publicado: (2022)

Nitric Oxide: The Coming of the Second Messenger*
por: Murad, Ferid
Publicado: (2011)

Antioxidants and Second Messengers of Free Radicals
por: Zarkovic, Neven
Publicado: (2018)

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
por: Iaboni, Aled, et al.
Publicado: (2022)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?()
por: Melgosa Ramos, F. Javier, et al.
Publicado: (2021)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Zinc is a novel intracellular second messenger
por: Yamasaki, Satoru, et al.
Publicado: (2007)

Nucleotide second messengers in bacterial decision making
por: Thompson, Catriona MA, et al.
Publicado: (2020)

Putative nucleotide-based second messengers in archaea
por: van der Does, Chris, et al.
Publicado: (2023)

Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines
por: Wolff, Jonathan, et al.
Publicado: (2021)

A Case of Leg Pain After the Initial Dose of the COVID-19 Vaccine, Followed by Deep Vein Thrombosis and Pulmonary Embolism After the Second Dose
por: Nagao, Michiru, et al.
Publicado: (2023)

The Single or Second Dose
por: Gregg, Rollin R.
Publicado: (1885)

Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers
por: Maruyama, Ayano, et al.
Publicado: (2022)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine
por: Mintz, Michelle Amy, et al.
Publicado: (2022)

The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study
por: El-Shitany, Nagla A, et al.
Publicado: (2022)

Immune response to second dose of MMR vaccine in Indian children
por: Gomber, Sunil, et al.
Publicado: (2011)

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
por: Mattiuzzi, Camilla, et al.
Publicado: (2023)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

The pros and cons of the second booster dose of the COVID-19 vaccine
por: Mostafavi, Ehsan
Publicado: (2022)

Transient dermatomyositis-like reaction following COVID-19 messenger RNA vaccination
por: Gutierrez, Rodrigo A., et al.
Publicado: (2023)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ireagfe87ik0dhe0uk9q5dvm0